Interpretation The cardioprotective effects of semaglutide were independent of baseline adiposity and weight loss and had only a small association with waist circumference, suggesting some mechanisms for benefit beyond adiposity reduction.
(Funded by Novo nordisk)
Found via https://archive.is/URt7Y (the australian)